CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.94
Delayed Data
As of 3:59pm ET
 +0.03 / +1.57%
Today’s Change
1.15
Today|||52-Week Range
3.82
-37.22%
Year-to-Date
Week In Review: BeiGene Signs $540 Million Deal For China Rights To 3 HBV Candidates
Jul 26 / Seeking Alpha - Paid Partner Content
CASI Pharma +11.9% as CEO buys nearly $7.9M in shares
Jul 24 / Seeking Alpha - Paid Partner Content
CASI Pharma +11.9% as CEO buys nearly $7.9M worth
Jul 24 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close1.91
Today’s open1.89
Day’s range1.89 - 2.04
Volume22,899
Average volume (3 months)346,479
Market cap$228.5M
Data as of 3:59pm ET, 08/11/2020

Growth & Valuation

Earnings growth (last year)-48.04%
Earnings growth (this year)+37.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.77
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
AQSTAquestive Therapeuti...-0.37-5.32%
MISTMilestone Pharmaceut...-0.58-6.12%
AGRXAgile Therapeutics I...-0.09-3.35%
EVLOEvelo Biosciences In...+0.10+2.04%
Data as of 4:23pm ET, 08/11/2020

Financials

Next reporting dateNovember 17, 2020
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$4.1M
Annual profit (last year)-$46.0M
Net profit margin-1,114.31%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts